drugset
drugset / Trial / NCT03998982

Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP

NCT03998982 ↗

Phase 4 Unknown 30 enrolled Shandong University
RandomizedParallel-groupDouble-blindTreatment

Summary

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of glycyrrhetinic acid combining with high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Timeline

Start
2019-06-25
Primary completion
2021-06-10
Completion
2021-06-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 40 mg Oral
Comparator Glycyrrhetinic Acid Unknown 75 mg Oral

Indications

autoimmune thrombocytopenia